Key facts
- Notable investors include QS Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Malin Lanrui Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Malin Lanrui Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Malin Lanrui Biotechnology
Operator of a marine-derived biotechnology compounds firm intended for applications in health, nutrition, and cosmetic formulations. The company offers to utilize extraction and purification technologies tailored to bioactive substances sourced from marine organisms, serving pharmaceutical, nutraceutical, and personal care markets to access stable, high-purity ingredients with consistent performance across diverse formulation environments, including temperature-sensitive and pH-variable conditions.
- Sector
- Healthcare
- HQ
- Xiamen, China
- Founded
- 2023
- Website
- marinesharp.com/
- Ownership
- Privately Held (backing)
Malin Lanrui Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Malin Lanrui Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Malin Lanrui Biotechnology in its N-PORT filings yet. We sweep new filings monthly.